The groundbreaking rise of Viagra has firmly established as a example of pharmaceutical success, but its position within the broader industry now triggers questions about potential returns . Generic versions are eroding patent protection , leading to worries that betting on companies closely tied to Viagra's previous influence could be a dangerous